Overview

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to find the highest dose of mafosfamide that can be given without causing severe side effects, to see how well the combination of these chemotherapy drugs and lower doses of radiation work to delay or stop the growth of the tumor, and to evaluate the pharmacokinetics (how the body handles) of Mafosfamide.
Phase:
N/A
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Children's Hospital of Philadelphia
Children's Hospital of Pittsburgh
Children's National Research Institute
Children's Research Institute
Dana-Farber Cancer Institute
Duke University
Seattle Children's Hospital
St. Jude Children's Research Hospital
Texas Children's Hospital
University of California, San Francisco
University of Pittsburgh
Treatments:
Cyclophosphamide
Mafosfamide